TOVX · Theriva Biologics, Inc.

Summary

On February 18, 2026, Theriva Biologics, Inc. entered into a License Agreement with Rasayana Therapeutics, constituting a material definitive agreement. The agreement is furnished as Exhibit 10.1, with a related press release as Exhibit 99.1 under Item 7.01.

Key takeaways

• Effective Date: February 18, 2026
• Parties: Theriva Biologics, Inc. and Rasayana Therapeutics
• Agreement Type: License Agreement
• Exhibit 10.1: License Agreement
• Exhibit 99.1: Press Release (Item 7.01)
• Filing Date: 2026-02-18